EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Medication use before and after bariatric surgery: 5-year results from a randomised controlled trial of banded Roux-en-Y gastric bypass versus sleeve gastrectomy in patients with obesity and type 2 diabetes

James Tan, Talat Nur, Bronwen Jones, Rinki Murphy, David Kim, Richard Cutfield, Lindsay D Plank, Michael Booth

New Zealand Medical Journal · 2024

DOI: 10.26635/6965.6442 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New Zealand Medical Journal, 2024. Verfasst von James Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, North Shore Hospital, Te Whatu Ora - Waitematā, Shakespeare Road, Takapuna, Auckland 0622, New Zealand. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastric Bypass, Gastrectomy. Gefördert von: Waitematā District Health Board, Johnson & Johnson (New Zealand), Covidien (New Zealand), Auckland Medical Research Foundation and Obex (New Zealand)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

aim: Bariatric surgery is an effective tool for weight loss and for improving weight related co-morbidities. Changes in medication usage after a silastic ring laparoscopic Roux-en-Y gastric bypass (SR-LRYGB) compared with laparoscopic sleeve gastrectomy (LSG) are unknown. methods: This was a single-centre, double-blind, randomised controlled trial. Patients were randomised to either SR-LRYGB or LSG. A medication history was obtained at regular follow-up intervals, and mean numbers of prescribed medications were analysed over 5 years. Poisson regression and generalised estimating equations were used to test for statistically significant changes in usage. results: After eight patients were lost to follow-up, data from 52 patients in each group were available for analysis. There was no difference between the SR-LRYGB or LSG groups in the number of medications prescribed, with the exception of oral glucose-lowering medications, where there was a greater decrease after SR-LRYGB compared to LSG (79% vs 55% respectively) from baseline to 5 years. At 5 years, total medication prescribed was down 10% from pre-operative levels. Prescribed insulin decreased by 72%, and cardiovascular medication decreased by 56% compared to baseline. Prescriptions for analgesia increased by 50%, psychiatric medications by 133% and proton-pump inhibitors by 81%. conclusion: Both SR-LRYGB and LSG reduced requirement for diabetic and cardiovascular medications, but increased requirement for nutritional supplementation, analgesia and psychiatric medications. There was a greater reduction in oral anti-diabetic medication prescriptions following SR-LRYGB compared to LSG, but no other difference in medication usage between surgical groups was found.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Gastric BypassGastrectomyHumansFemaleMaleDouble-Blind MethodMiddle AgedAdultObesity, MorbidHypoglycemic AgentsWeight LossLaparoscopyTreatment Outcome

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • Department of Surgery, North Shore Hospital, Te Whatu Ora - Waitematā, Shakespeare Road, Takapuna, Auckland 0622, New Zealand.
  • Department of Medicine, Faculty of Medical and Health Sciences, The University of Auckland, M&HS Building 507, 28 Park Ave, Grafton, Auckland 1023, New Zealand.
  • Department of Endocrinology, North Shore Hospital, Te Whatu Ora - Waitematā, Shakespeare Road, Takapuna, Auckland 0622, New Zealand.
  • Department of Surgery, Faculty of Medical and Health Sciences, The University of Auckland, M&HS Building 507, 28 Park Ave, Grafton, Auckland 1023, New Zealand.

Förderung

  • Waitematā District Health Board, Johnson & Johnson (New Zealand), Covidien (New Zealand), Auckland Medical Research Foundation and Obex (New Zealand).

Zitieren

APA

Tan, J., Nur, T., Jones, B., Murphy, R., Kim, D., Cutfield, R., Plank, L. D., & Booth, M. (2024). Medication use before and after bariatric surgery: 5-year results from a randomised controlled trial of banded Roux-en-Y gastric bypass versus sleeve gastrectomy in patients with obesity and type 2 diabetes. New Zealand Medical Journal. https://doi.org/10.26635/6965.6442

Vancouver

Tan J, Nur T, Jones B, Murphy R, Kim D, Cutfield R, et al. Medication use before and after bariatric surgery: 5-year results from a randomised controlled trial of banded Roux-en-Y gastric bypass versus sleeve gastrectomy in patients with obesity and type 2 diabetes. New Zealand Medical Journal. 2024. doi:10.26635/6965.6442

BibTeX
@article{Tan2024,
  author = {Tan, James and Nur, Talat and Jones, Bronwen and Murphy, Rinki and Kim, David and Cutfield, Richard and Plank, Lindsay D and Booth, Michael},
  title = {Medication use before and after bariatric surgery: 5-year results from a randomised controlled trial of banded Roux-en-Y gastric bypass versus sleeve gastrectomy in patients with obesity and type 2 diabetes},
  journal = {New Zealand Medical Journal},
  year = {2024},
  doi = {10.26635/6965.6442}
}
Kostenlos starten →